Loading clinical trials...

ROTATEQ™ Post-Marketing Surveillance in the Philippines | Clinical Trials | Clareo Health

Back to search

TERMINATED

ROTATEQ™ Post-Marketing Surveillance in the Philippines

Protocol for ROTATEQ™ Post-Marketing Surveillance

NCT01357174•Merck Sharp & Dohme LLC

View on ClinicalTrials.gov

Summary

This study will collect demographic and safety information on the use of ROTATEQ™ in the Philippines.

Eligibility

Age

0 - 0 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Received ROTATEQ™

Key Dates

Start Date

October 1, 2007

Primary Completion Date

September 1, 2010

Completion Date

September 1, 2010

Last Updated

October 30, 2015

Enrollment

915

ACTUAL participants

Conditions

Rotavirus InfectionsGastroenteritis

Eosinophilic Gastrointestinal Disorders Registry

NCT05199532

Eosinophilic EsophagitisEosinophilic Gastroenteritis+2 more

View study

ACTIVE_NOT_RECRUITINGPHASE1

CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults

NCT06962904

Rotavirus Infections

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 30, 2015Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

ACTIVE_NOT_RECRUITING